Mammogram facilities will need to follow some new rules soon.
The U.S. Food and Drug Administration (FDA) on Thursday released updated regulations that require mammogram providers to notify patients about the density of their breast tissue.
The updates apparently will give the FDA more oversight as well over individual mammography facilities — with the purported goal of improving patient care and communications.
During a screening mammogram, a radiologic technologist uses a special X-ray machine to detect any abnormalities that could indicate a risk of breast cancer. The images show whether a woman has dense breast tissue, which can make it more difficult to spot cancer warning signs.
BREAST CANCER AND MAMMOGRAMS: EVERYTHING YOU NEED TO KNOW ABOUT THE DISEASE, SCREENING AND MORE
Women with dense breast tissue are also at a higher risk of developing the disease.
“Today’s action represents the agency’s broader commitment to support innovation to prevent, detect and treat cancer,” said Hilary Marston, M.D., M.P.H., chief medical officer of the FDA in Silver Spring, Maryland, in a press release announcing the new regulations.
H/T Fox News (read more at FoxNews.com)
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of Being Healthy News. Contact us for guidelines on submitting your own commentary.
Leave a comment
COMMENTS POLICY: We have no tolerance for messages of violence, racism, vulgarity, obscenity or other such discourteous behavior. Thank you for contributing to a respectful and useful online dialogue.